Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729753 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate CryoBalloon™ Full and Swipe Ablation Systems for Ablation of Human Esophageal Epithelium
A NA study of Esophageal Cancer, sponsored by Pentax Medical.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT02729753 is a NA study of Esophageal Cancer that has completed, run by Pentax Medical. The registered enrollment target is 10 participants, below the 499-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02729753, a NA study of Esophageal Cancer, has completed, sponsored by Pentax Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate the C2 CryoBalloon™ Full and Swipe Ablation Systems for the ablation of human esophageal epithelium in patients scheduled to undergo esophagectomy for reasons unrelated to the objective of the study
Conditions Studied
Interventions
- DEVICE CryoBalloon™ Full Ablation System
- DEVICE CryoBalloon™ Swipe Ablation System
Study Locations (2)
Texas
- MD Anderson Cancer Center - Houston
Washington
- Swedish Medical Center and Cancer Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729753
The ClinicalTrials.gov registry entry for NCT02729753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Pentax Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Esophageal Cancer appearing as the primary indexed condition, and to 2 interventions - of which CryoBalloon™ Full Ablation System is the first listed.
NCT02729753 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Washington.
Frequently Asked Questions
What is clinical trial NCT02729753 about?
NCT02729753 is a clinical study titled "Clinical Study to Evaluate CryoBalloon™ Full and Swipe Ablation Systems for Ablation of Human Esophageal Epithelium". This study will evaluate the C2 CryoBalloon™ Full and Swipe Ablation Systems for the ablation of human esophageal epithelium in patients scheduled to undergo esophagectomy for reasons unrelated to the objective of the study
What is the current status of trial NCT02729753?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-04. Estimated completion is 2016-10-30.
What conditions does trial NCT02729753 study?
This clinical trial studies the following conditions: Esophageal Cancer.
What interventions are being tested in trial NCT02729753?
The interventions under investigation include: CryoBalloon™ Full Ablation System (DEVICE), CryoBalloon™ Swipe Ablation System (DEVICE).
Who is sponsoring clinical trial NCT02729753?
This trial is sponsored by Pentax Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02729753 being conducted?
This trial has 2 study locations across Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
RECRUITING · NA
-
Exercise Prehabilitation for Locoregional Esophageal Cancer
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Serial MRI Scans During Radiation Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.